Whereas some authors have indicated that high levels of CDK9 expression in patients with pancreatic adenocarcinoma are associated with significantly shortened OS, especially in well differentiated tumors [36,41,42], others have demonstrated that higher CDK9 expression is associated with significantly improved survival [43,44]. Here, CDK9 is linked to pancreatic adenocarcinoma.